New Hospital Networks for Antimicrobial Stewardship in Vietnam
23 December 2024
OUCRU Ha Noi and the National Hospital for Tropical Diseases (NHTD), under the guidance of the Department of Health, are collaborating to establish local hospital networks for Antimicrobial Stewardship (AMS) across Vietnam. This initiative, connecting district hospitals with provincial hospitals, leverages existing systems and resources to enhance AMS implementation and strengthen efforts against antimicrobial resistance (AMR).
National reference labs are key to effectively managing endemic and pandemic infectious diseases
20 December 2024
National microbiology reference laboratories are central to global health and must be adequately funded, according to a viewpoint article published in The Lancet Digital Health by researchers at Oxford Population Health and the Invasive Respiratory Infection Surveillance (IRIS) Consortium.
Winners of new “After the End” poetry competition announced
20 December 2024
Nigerian poet, Chiwenite Onyekwelu, is the winner of the first poetry competition to consider concepts of endings, with his poems ‘On Memory and Forgetting’ and ‘Time/Our Time’. ‘On Memory and Forgetting’ describes Onyekwelu’s father’s recollections of the Biafra war and ‘Time/ Our Time’ reflects on the impact of oil spills into the Niger Delta.
New study reveals the COVID-19 pandemic’s impact on other causes of death
20 December 2024
An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.
Optimising testing for disease surveillance with machine learning
19 December 2024
A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.
Certain antimalarial drugs show moderate effect in preventing COVID-19
19 December 2024
Mahidol Oxford Tropical Medicine Research Unit (MORU) have led the world’s largest study on the use of hydroxychloroquine and chloroquine to prevent COVID-19. With results showing moderate protection against the virus, the trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a placebo.
Current WHO guidelines may not be relevant for accurately monitoring schistosomiasis-related disease
18 December 2024
A new study by researchers at the Big Data Institute indicates that current World Health Organization (WHO) guidelines for monitoring the control and elimination of schistosomiasis-related disease, especially severe disease such as periportal fibrosis (PPF), may not give an accurate picture of how many people are affected. The study is published in The Lancet Global Health.
Launch of largest-ever study tracking chikungunya burden in East Africa
13 December 2024
A team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa.
What psychology reveals about climate worry and the ensuing will to engage in sustainable action
11 December 2024
A researcher at the Environmental Change Institute has been studying how climate change impacts people’s mental health and their subsequent ability to take action.
Trial results for first vaccine against blood-stage malaria show it is well-tolerated and offers effective protection
10 December 2024
Results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-M) show it is well-tolerated and offers effective protection against the blood-stage of the disease – the first inoculation to do so.
PSI’s Md Zakiul Hassan recognised as 2024 ISID Emerging Leader
10 December 2024
The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.
OUCRU workshop bridges research and clinical practice on Pneumococcal infections
4 December 2024
On November 22, 2024, the Zoonoses research group at OUCRU, in collaboration with Children's Hospital 2, Ho Chi Minh City, successfully organised a scientific workshop: "Community-acquired pneumonia: Update on pneumococcal infection with vaccines, drug resistance and multiple infections". The workshop attracted nearly 70 experts, including doctors, nurses, medical students, and technicians.
AMR booklet by Shuma Banik
3 December 2024
IHTM alumna, Shuma Banik, has written and painted a booklet about the growing problem of antimicrobial resistance (AMR) in Assam, India.
Oxford Clinical Lecturer awarded prestigious BIA Barnet Christie Lecture
2 December 2024
Xin Hui Chan has won the competitive 2024 Barnet Christie Lecture award of the British Infection Association. As part of the award, Dr Chan delivered a lecture entitled ‘Drugs for Tropical Infections: Challenges, Opportunities, and the Infectious Disease Physician’
Land travel and local mobility played a key role in COVID-19 spread in Chile
29 November 2024
An international team led by researchers from the Oxford Martin Programme on Pandemic Genomics studied how local travel patterns and mobile data from Chile can improve global pandemic responses, highlighting the importance of land-based mobility and targeted strategies.
KEMRI renews collaboration with Wellcome Trust and University of Oxford
27 November 2024
The Kenya Medical Research Institute (KEMRI) has signed a seven-year Memorandum of Agreement with Wellcome Trust, a UK charitable organization, and the University of Oxford, on Wednesday 27 November 2024, at the KEMRI Headquarters, Nairobi. Under this collaboration, Wellcome has awarded GBP 91 million (KES 15 billion) to support research over the next 7 years.
Eating less sugar would be great for the planet as well as our health
27 November 2024
Sugar addiction is on the rise. Globally, sugar intake has quadrupled over the last 60 years, and it now makes up around 8% of all our calories.
NDM unit awarded £11m to address antimicrobial resistance
22 November 2024
The National Institute for Health and Care Research (NIHR) has awarded the Modernising Medical Microbiology consortium £11 million to address major public health threat, antimicrobial resistance. The Oxford Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, hosted by the Nuffield Department of Medicine since 2014, is one of 13 HPRUs funded by NIHR as part of an £80 million funding boost.
Understanding blood proteins can improve risk prediction for heart attacks
22 November 2024
A study by researchers from Oxford Population Health and Peking University, has shown that proteins carried in the blood could improve our ability to predict a person’s risk of heart attack beyond conventional risk factors such as high blood pressure and genetic predisposition. The study is published in European Journal of Epidemiology.
Study finds methaemoglobin levels could predict malaria recurrence
22 November 2024
A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.